Asked by: James McMurdock (Independent - South Basildon and East Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve access to treatment and engagement with services for people experiencing alcohol dependence in South Basildon and East Thurrock constituency.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to ensuring that anyone with an alcohol problem can access the help and support they need, including in South Basildon and East Thurrock, and we recognise the need for evidence-based, high-quality treatment.
Local authorities are responsible for commissioning alcohol and drug treatment and recovery services as part of their public health responsibilities. As a condition of the Public Health Grant, local authorities are responsible for improving the uptake of, and outcomes from, their alcohol and drug treatment services, based on an assessment of local need and a plan which has been developed with local health and criminal justice partners. From 2026/27, all alcohol and drug treatment and recovery funding will be ringfenced and channelled through the Public Health Grant. Through the ringfenced funding, Essex will receive £11,023,044 in 2026/27 and indicative totals of £11,247,572 and £11,466,588 for 2027/28 and 2028/29 respectively. Thurrock will receive £1,588,644 in 2026/27 and indicative totals of £1,621,003 and £1,652,567 for 2027/28 and 2028/29 respectively.
The Department, with the support of partners from the devolved administrations, has developed and published the first ever United Kingdom clinical guidelines on alcohol treatment. This is available at the following link:
https://www.gov.uk/guidance/clinical-guidelines-for-alcohol-treatment
The aim of the guidelines is to promote and support good practice and improve the quality of service provision, resulting in better outcomes for people experiencing harmful drinking and alcohol dependence.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent discussions his Department has had with cancer charities on supporting people with hair loss accessing hair systems.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department and the National Health Service in England acknowledge that some cancer patients may face difficulties with hair loss during treatment.
Decisions about the funding and provision of health services are the responsibility of local integrated care boards. NHS Supply Chain has engaged extensively on a national level to thoroughly assess the provision and supply of wigs and related accessories. Collaboration between NHS Supply Chain with industry groups is ongoing to facilitate access to the wigs framework, thereby offering NHS providers a broader selection of products. A key priority throughout this process has been ensuring suitability for individual wearers.
Asked by: Allison Gardner (Labour - Stoke-on-Trent South)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his department is taking to improve awareness and understanding of Type 1 Diabetes across the Health and Social Care system.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
As I reaffirmed in the Westminster Hall debate on type 1 diabetes on 9 March 2026, the Government is committed to improving awareness of type 1 diabetes. NHS England carried out communications activity to coincide with World Diabetes Day in November 2025, with a focus on the “4Ts” symptoms of type 1 diabetes, namely thirst, tired, thinning, and toileting, meaning increased urine output. This included messaging to the public via social media, and the cascade of information via clinical networks.
NHS England is currently engaging and coordinating with other national organisations on supportive action, raising awareness of the symptoms of type 1 diabetes, improving training and education, and exploring what supportive tools may be available to further support healthcare professionals to identify type 1 diabetes.
Asked by: Sarah Coombes (Labour - West Bromwich)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, after factoring in the national decline in healthy life expectancy referenced in the answer of 3 March 2026 to Question 115639, for what reason Sandwell has seen a further decline in HLE for men and women since 2020.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
According to the Office for National Statistics, the COVID-19 pandemic led to increased mortality during 2020, 2021, and 2022, and explains the national decline observed in healthy life expectancy (HLE) since 2020. Some negative impact remains in the latest reporting period, from 2022 to 2024. Further information is available at the following link:
HLE at birth for Sandwell stood at 51.3 years for females and 52.7 years for males for the latest period 2022 to 2024. This compares to 61.3 and 60.9 years for females and males respectively, for England.
HLE is a broad summary measure of population health, combining mortality rates and self-reported health, at various ages. This can make it difficult to interpret the reasons behind the changes observed, especially as HLE is known to be influenced by a wide range of social, economic, environmental, and behavioural factors.
The Government recognises that health inequalities can widen if access and quality of healthcare are worse where need is greatest. Therefore, over the course of our 10-Year Health Plan, we aim to establish a Neighbourhood Health Centre in every community, transforming healthcare access by bringing historically hospital-based services into communities and addressing wider determinants of health through services like debt advice, employment support, and obesity management programmes.
Nationwide coverage will take time, but we will start in the areas of greatest need where healthy life expectancy is lowest, including rural towns and communities with higher deprivation levels and delivering healthcare closer to home for those that need it the most.
Asked by: Sarah Coombes (Labour - West Bromwich)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the answer of 3 March 2026 to question 115639, what factors are behind the national decline in healthy life expectancy since 2020.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
According to the Office for National Statistics, the COVID-19 pandemic led to increased mortality during 2020, 2021, and 2022, and explains the national decline observed in healthy life expectancy (HLE) since 2020. Some negative impact remains in the latest reporting period, from 2022 to 2024. Further information is available at the following link:
HLE at birth for Sandwell stood at 51.3 years for females and 52.7 years for males for the latest period 2022 to 2024. This compares to 61.3 and 60.9 years for females and males respectively, for England.
HLE is a broad summary measure of population health, combining mortality rates and self-reported health, at various ages. This can make it difficult to interpret the reasons behind the changes observed, especially as HLE is known to be influenced by a wide range of social, economic, environmental, and behavioural factors.
The Government recognises that health inequalities can widen if access and quality of healthcare are worse where need is greatest. Therefore, over the course of our 10-Year Health Plan, we aim to establish a Neighbourhood Health Centre in every community, transforming healthcare access by bringing historically hospital-based services into communities and addressing wider determinants of health through services like debt advice, employment support, and obesity management programmes.
Nationwide coverage will take time, but we will start in the areas of greatest need where healthy life expectancy is lowest, including rural towns and communities with higher deprivation levels and delivering healthcare closer to home for those that need it the most.
Asked by: Chris Evans (Labour (Co-op) - Caerphilly)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the answer of 21 November 2025 to question 90178, if his Department will make an assessment of the adequacy of the capacity of NHS pathology services for fresh-freezing brain cancer and other tumour tissue samples.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
Standard operating procedures (SOPs) for the fresh-freezing of tissue examples have already been developed across pathology networks in England. It is, however, the responsibility of individual pathology services to maintain their own SOPs for the fresh-freezing of tissue samples. These protocols outline local capabilities and practices.
There are no current plans to introduce one standardised approach for the fresh-freezing of tissue samples. NHS England is committed to addressing variation in the provision of pathology services, particularly histopathology, of which the investigation of brain and neural tissues is a core element.
The Department is exploring options to expand brain tissue freezing capacity.
Asked by: Chris Evans (Labour (Co-op) - Caerphilly)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the answer of 21 November to question 90178, what assessment his Department has made of the potential merits of introducing a standardised approach to tissue freezing.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
Standard operating procedures (SOPs) for the fresh-freezing of tissue examples have already been developed across pathology networks in England. It is, however, the responsibility of individual pathology services to maintain their own SOPs for the fresh-freezing of tissue samples. These protocols outline local capabilities and practices.
There are no current plans to introduce one standardised approach for the fresh-freezing of tissue samples. NHS England is committed to addressing variation in the provision of pathology services, particularly histopathology, of which the investigation of brain and neural tissues is a core element.
The Department is exploring options to expand brain tissue freezing capacity.
Asked by: Chris Evans (Labour (Co-op) - Caerphilly)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the answer of 21 November 2025 to question 90178, what steps his Department is taking to develop standard operating procedures for the handling and freezing of fresh tissue samples.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
Standard operating procedures (SOPs) for the fresh-freezing of tissue examples have already been developed across pathology networks in England. It is, however, the responsibility of individual pathology services to maintain their own SOPs for the fresh-freezing of tissue samples. These protocols outline local capabilities and practices.
There are no current plans to introduce one standardised approach for the fresh-freezing of tissue samples. NHS England is committed to addressing variation in the provision of pathology services, particularly histopathology, of which the investigation of brain and neural tissues is a core element.
The Department is exploring options to expand brain tissue freezing capacity.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will outline a timeline he expects there to be standard treatment for recurrent glioblastoma available in the UK.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government recognises that there are currently limited treatment options available for people who have been diagnosed with cancerous brain tumours, such as glioblastoma, and recognises the significant impact that this rare cancer can have on patients, carers, and their families.
In October 2025, a new nationwide trial was launched exploring whether surgery can improve the quality of life for patients when glioblastoma comes back after treatment commenced, backed by £1.98 million of National Institute of Health and Care Research (NIHR) funding.
The Government published the National Cancer Plan for England on 4 February 2026, and it was the first ever cancer plan to include a chapter on rare and less common cancers. The plan sets out that we will aim to reduce the number of cancers diagnosed in emergency settings.
To accelerate breakthroughs, the Government will explore innovative procurement methods, such as advance market commitments, to stimulate the development of new diagnostic tests, targeted therapies and more effective treatments for rare cancers, such as brain cancers.
As a result of the significant new commitments to brain tumour research being announced, committed spend on brain tumour research from NIHR programmes alone is now in excess of £40 million since 2018. This is in addition to NIHR investments in infrastructure, which are estimated to be £44.5 million over the period 2018/19 to 2024/25, and UK Research and Innovation commitments of £46.8 million to brain tumour research over the six years from 2018/19 to 2023/24.
Asked by: Lee Anderson (Reform UK - Ashfield)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential impact of staffing levels in cancer care on waiting times for patients to receive treatment.
Answered by Sharon Hodgson - Parliamentary Under-Secretary (Department of Health and Social Care)
The development of the National Cancer Plan highlighted areas where there are higher vacancy rates in some areas of the country. The Department and NHS England will work with the royal colleges to encourage resident doctors and internal medicine trainees to specialise in clinical and medical oncology to address these pressures. NHS England will also use training more directly as a lever to support improvements in operational performance, prioritising training places in trusts, often those in rural or coastal areas, where vacancy rates are higher and performance is lower.
Through these interventions, patients will see improvements now, and these training places will secure the workforce for the future. The Department has committed to the National Health Service meeting all cancer waiting time standards by the end of this Parliament, ending a decade of missed targets.
The NHS is determined to cut cancer waiting lists and treatment times. That is why the Department is investing £70 million in new radiotherapy machines in the NHS and opening 170 community diagnostic centres to speed up diagnosis. Furthermore, the NHS will continue to look at opportunities to use artificial intelligence, for example by helping oncologists plan radiotherapy more quickly and accurately. Improved contouring in radiotherapy practice will mean better outcomes and reduced risk of healthy tissue damage, meaning fewer complications for patients and less need for follow up treatment.